Tactile Medical Unveils Lighter AffloVest with Built-in Wi-Fi and Bluetooth
TCMD•Tactile Medical launched its next-generation AffloVest system featuring reduced weight, expanded size adjustability and built-in Wi-Fi and Bluetooth to enhance patient comfort and support remote therapy monitoring. The device preserves its clinical HFCWO foundation for treating cystic fibrosis, bronchiectasis and neuromuscular disorders across all age groups.
1. Commercial Launch
Tactile Medical has begun full commercial rollout of its next-generation AffloVest high-frequency chest wall oscillation system, maintaining its indication for use as an airway clearance therapy for chronic neuromuscular and respiratory conditions.
2. Design and Comfort Enhancements
The new AffloVest features a lighter, more adjustable vest catering to pediatric through geriatric patients and a redesigned, intuitive controller to simplify setup, operation and overall treatment comfort.
3. Connectivity and Data Insights
Built-in Wi-Fi and Bluetooth connectivity allow patients to visualize their therapy progress via a connected app, while clinicians and DME providers access real-world utilization data to guide personalized care and support reimbursement requirements.
4. Market Outlook
Available ahead of the winter respiratory season, the updated AffloVest aims to drive adoption among cystic fibrosis, bronchiectasis and neuromuscular disorder patients in both home and clinical settings, potentially boosting sales in the upcoming quarters.
